Dr. Pradeep Chatterjee completed his undergraduate studies in Chemistry from the Indian Institute of Technology, Kharagpur and Indian Institute of Technology, Kanpur, India. He received his Ph.D. in Chemistry from Columbia University, New York, developing novel technology to generate psoralen-DNA monoadducts photochemically. His postdoctoral training at MIT, Cambridge, Massachusetts, elucidated the role of the cytoskeleton to assemble the nucleocapsid proteins of Vescicular Stomatis Virus. His studies continued at Princeton University, Princeton, with adenovirus nucleoprotein assembly and eukaryotic gene transcription. Dr. Chatterjee then joined DuPont-Merck to study mechanisms of cell killing by antitumor drugs using both biochemical and genetic approaches. He joined BBRI-NCCU in 1999 to start a research program in genomics. His research interests include application of genomic and molecular genetic technologies to understand eukaryotic gene regulation using the zebrafish model system, and developing new technology to map genetic markers and cis-acting gene-regulatory elements that influence expression from large distances along the DNA.